Laura C. Seidman

ORCID: 0000-0003-1442-0981 · 11 papers in corpus
observational 2026
Frontiers in pain research (Lausanne, Switzerland) ·doi:10.3389/fpain.2026.1878751

INTRODUCTION: Non-steroidal anti-inflammatory drugs (NSAIDs) are considered a first-line treatment for dysmenorrhea (menstrual pain). However, as much as 20% of women fail to achieve sufficient pain relief from NSAIDs, although factors asso…

other 2026
Vaccine ·doi:10.1016/j.vaccine.2026.128226

PURPOSE: Changes in menstrual cycle characteristics following COVID-19 vaccination have been reported in women and adolescent girls, yet the biological mechanisms underlying these changes remain poorly understood. Inflammation, though frequ…

observational 2025
Pain ·doi:10.1097/j.pain.0000000000003334

Menstrual pain is associated with deficits in central pain processing, yet neuroimaging studies to date have all been limited by focusing on group comparisons of adult women with vs without menstrual pain. This study aimed to investigate th…

observational 2025
Pain reports ·doi:10.1097/pr9.0000000000001315

INTRODUCTION: The Menstrual Sensitivity Index (MSI), assessing the attunement to and fear of menstrual symptoms, was recently developed and validated in an adult sample. OBJECTIVES: The objective of this study was to validate the MSI in ad…

other 2024
The Journal of adolescent health : official publication of the Society for Adolescent Medicine ·doi:10.1016/j.jadohealth.2024.06.023

PURPOSE: The current study aimed to evaluate the impact of the COVID-19 booster vaccine on menstrual cycle characteristics in adolescent girls (aged 13-20) compared to those who did not receive a booster vaccine. METHODS: This prospective …

observational 2021
Psychology, health & medicine ·doi:10.1080/13548506.2021.1948581

The aim of this study was to understand the relationship between psychosocial factors, including mental health, pain cognitions and social support associated with menstrual pain severity in women with dysmenorrhea of no identified medical c…

observational 2020
Journal of pain research ·doi:10.2147/jpr.s283363

PURPOSE: Primary dysmenorrhea (PD; menstrual pain without an identified organic cause) has been proposed as a possible risk factor for the development of chronic pelvic pain, but the mechanism through which this process occurs is unknown. O…

observational 2020
Pain medicine (Malden, Mass.) ·doi:10.1093/pm/pnaa362

OBJECTIVE: Primary dysmenorrhea and secondary dysmenorrhea due to endometriosis share overlapping symptoms and likely demonstrate aspects of central sensitization. The present study aimed to identify distinct phenotypes of women who have dy…

qualitative 2020
Journal of advanced nursing ·doi:10.1111/jan.14460

AIMS: To understand the experiences of adolescents and young adults with primary dysmenorrhoea through the lens of structured frameworks extant in contemporary pain literature. DESIGN: Descriptive qualitative study. METHODS: Thirty-nine a…

observational 2019
Pain ·doi:10.1097/j.pain.0000000000001516

Primary dysmenorrhea (PD; menstrual pain without an underlying medical condition) is associated with enhanced pain sensitivity and temporal summation (TS) in adult women, which may reflect the presence of central pain processes. Research in…

review 2017
Journal of pain research ·doi:10.2147/jpr.s143512

Primary dysmenorrhea (PD) has been the focus of a number of experimental pain studies. Although a number of reviews exist, few have critically evaluated the existing body of research on PD and experimental and procedural pain. Data from 19 …